Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation

Transplant Proc. 1996 Dec;28(6):3246-7.

Authors

S Jonas¹, W O Bechstein, N Rayes, R Neuhaus, O Guckelberger, S G Tullius, G Schmidt, H Riess, H Lobeck, T Vogl, P Neuhaus

Affiliation

¹ Department of Surgery, Virchow Medical Center, Humboldt University, Berlin, Germany.

PMID: 8962257

No abstract available

MeSH terms

Carcinoma, Hepatocellular / epidemiology
Cyclosporine / therapeutic use
Follow-Up Studies
Hepatitis B / surgery
Hepatitis C / surgery
Humans
Immunosuppressive Agents / therapeutic use
Liver Cirrhosis / surgery
Liver Neoplasms / epidemiology
Liver Transplantation / immunology*
Lymphoma / epidemiology
Neoplasms / epidemiology*
Neoplasms / etiology
Postoperative Complications*
Retrospective Studies
Tacrolimus / therapeutic use
Time Factors

Substances

Immunosuppressive Agents
Cyclosporine
Tacrolimus